Behavioral Therapies Development Program Addendum: Behavioral and Integrative Treatment of Methamphetamine Abuse and Dependence

Notice Number: NOT-DA-05-008

Key Dates
Release Date: March 25, 2005

Issued by
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)

This notice, Behavioral and Integrative Treatment of Methamphetamine Abuse and Dependence , is an addendum to Program Announcement PA-03-126, at http://grants.nih.gov/grants/guide/pa-files/PA-03-126.html, published in the NIH Guide, May 19, 2003. One purpose of this addendum is to encourage research on the development, refinement and testing of behavioral and integrative (combined or integrated behavioral and pharmacological and/or complementary/alternative) treatments for methamphetamine abuse and dependence. Another purpose of this addendum is to encourage research on the development, refinement and testing of HIV risk-reduction interventions for individuals in treatment for methamphetamine abuse or dependence. The translation of basic behavioral science and neuroscience research into creative new behavioral interventions for individuals addicted to methamphetamine in treatment is especially encouraged. The National Institute on Drug Abuse (NIDA) comprehensively supports the study of behavioral treatments and interventions (including, but not limited to behavioral, cognitive, family, couples, and systems therapies, psychotherapies, counseling approaches, and risk-reduction interventions) that will potentially have a significant impact on reducing drug abuse and addiction and reducing HIV/AIDS risk behaviors. This notice is meant to supplement Program Announcement PA-03-126, which should be consulted in conjunction with this addendum.

Research Objectives

Methamphetamine abuse is becoming increasingly more common, spreading both geographically as well as into new populations. Many behavioral treatments (and combined behavioral and pharmacological treatments) have been shown to be valuable in the treatment of other drugs of abuse, such as cocaine, nicotine, and marijuana. They have been shown to help with promoting initial abstinence from drugs, reducing total drug use, reducing relapse, decreasing HIV risk behaviors, etc. Nonetheless, there is a paucity of research on the treatment of methamphetamine abuse and dependence, and on how to reduce risk for infectious disease among methamphetamine abusers in drug abuse treatment. This notice seeks research applications in areas including, but not limited to:

Stage I Behavioral Treatment Research:

Stage II Behavioral Treatment Research:

Stage III Behavioral Treatment Research:

All applications must use grant application form PHS398 using the standard receipt dates described in the form. Updated instructions to the PHS398 Application are now available at http://grants.nih.gov/grants/forms.htm.

For further information on application preparation, contact Lisa_Onken@nih.gov.

Inquiries

Please direct inquiries on this notice and on PA-03-126 to:

Lisa Onken, Ph.D.
Chief, Behavioral and Integrative Treatment Branch
Division of Clinical Neuroscience, Development, and Behavioral Treatment
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Boulevard, Room 4234 MSC 9593
Bethesda, MD 20892-9593
Phone: (301) 443-2235
FAX: (301) 443-6814


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.